Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50

ClinicalTrials.gov ID: NCT04192630

Public ClinicalTrials.gov record NCT04192630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Document the Safety and Effectiveness of a New Cohesive OVD When Compared to a Control OVD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the study is to evaluate the safety and effectiveness of the Bausch \& Lomb CVisc50 cohesive OVD compared to the Alcon ProVisc® cohesive OVD when used in cataract surgery.

Study identification

NCT ID
NCT04192630
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Bausch & Lomb Incorporated
Industry
Enrollment
390 participants

Conditions and interventions

Conditions

Interventions

Device · Procedure

Eligibility (public fields only)

Age range
45 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 26, 2019 (Actual)
Primary completion
Jan 31, 2022 (Actual)
Completion
Jan 31, 2022 (Actual)
Last update posted
May 28, 2024

2019 – 2022

United States locations

U.S. sites
22
U.S. states
10
U.S. cities
21
Facility City State ZIP Site status
Bausch Site 017 Chandler Arizona 85224 —
Bausch Site 001 Phoenix Arizona 85032 —
Bausch Site 008 Fayetteville Arkansas 72704 —
Bausch Site 010 Burlingame California 94010 —
Bausch Site 007 Garden Grove California 92843 —
Bausch Site 011 Newport Beach California 92662 —
Bausch Site 012 Northridge California 91325 —
Bausch Site 013 Rancho Cordova California 95670 —
Bausch Site 004 Torrance California 90505 —
Bausch Site 019 Bloomington Minnesota 55420 —
Bausch Site 020 Kansas City Missouri 64154 —
Bausch Site 002 St Louis Missouri 63131 —
Bausch Site 015 Washington Missouri 63090 —
Bausch Site 005 New York New York 10013 —
Bausch Site 021 Mason Ohio 45040 —
Bausch Site 003 Reading Pennsylvania 96002 —
Bausch Site 014 Goodlettsville Tennessee 37073 —
Bausch 018 Nashville Tennessee 37215 —
Bausch Site 009 Cedar Park Texas 78613 —
Bausch Site 006 Houston Texas 77008 —
Bausch 022 San Antonio Texas 78215 —
Bausch Site 016 San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04192630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2024 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04192630 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →